FAQs
Most frequent questions and answers
Although Trublood™ detects CTCs with high accuracy, it is intended for use only in patients with clinical or radiological findings suspected of cancer. DCG has other tests which facilitate cancer detection in asymptomatic individuals (screening).
Trublood™ is a ‘Prescription Only’ test that can be ordered by a qualified and licensed medical practitioner (physician) for their patients.
While Trublood™ findings can facilitate more effective diagnosis of cancers in cases, it is not a replacement for standard diagnostic procedures. Trublood™ findings must be interpreted and used by a qualified and licensed medical practitioner in conjunction with other relevant clinical evidence and assessments for establishing a final diagnosis.
A ‘Positive’ report should be followed by immediate consultation with a physician for appropriate guidance and additional Standard of Care work up as may be advised.
For those with a ‘Negative’ test report, the appropriate further steps would be decided by the treating physician.
